QT
CRSP icon

Quantbot Technologies’s CRISPR Therapeutics CRSP Stock Holding History

Quantbot Technologies’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$975K Buy
17,880
+16,481
+1,178% +$869K 0.04% 649
2026
Q1 		$66.5K Sell
1,399
-785
-36% -$41.4K ﹤0.01% 1381
2025
Q4 		$115K Buy
+2,184
New +$131K ﹤0.01% 1387
2025
Q3 		– Sell
-612
Closed -$29.8K – 1793
2025
Q2 		$29.8K Sell
612
-725
-54% -$28.1K ﹤0.01% 1520
2025
Q1 		$45.5K Buy
1,337
+978
+272% +$41.5K ﹤0.01% 1330
2024
Q4 		$14.1K Buy
+359
New +$17K ﹤0.01% 1369
2024
Q2 		– Sell
-1,303
Closed -$88.8K – 1524
2024
Q1 		$88.8K Buy
+1,303
New +$93.3K 0.01% 1213
2023
Q4 		– Sell
-13
Closed -$590 – 1630
2023
Q3 		$590 Buy
+13
New +$671 ﹤0.01% 1481
2022
Q3 		– Sell
-67
Closed -$4K – 1672
2022
Q2 		$4K Buy
+67
New +$3.94K ﹤0.01% 1591
2021
Q3 		– Sell
-3,521
Closed -$570K – 1581
2021
Q2 		$570K Buy
+3,521
New +$428K 0.04% 508
2021
Q1 		– Sell
-167
Closed -$25K – 1466
2020
Q4 		$25K Buy
+167
New +$19.7K ﹤0.01% 978
2020
Q3 		– Sell
-721
Closed -$52K – 1341
2020
Q2 		$52K Buy
721
+519
+257% +$30.3K 0.01% 704
2020
Q1 		$8K Sell
202
-2,698
-93% -$139K 0.01% 708
2019
Q4 		$176K Buy
+2,900
New +$158K 0.02% 695
2018
Q2 		– Sell
-1,417
Closed -$64K – 1249
2018
Q1 		$64K Buy
+1,417
New +$58.5K 0.01% 943

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantbot Technologies's CRSP Position: Q2 2026 in Review

Quantbot Technologies increased its CRISPR Therapeutics (CRSP) stake by 1,178% in Q2 2026, buying an estimated $869K and bringing the position to 17,880 shares worth $975K. The position accounts for 0.04% of the portfolio, ranked #649.

Quantbot Technologies first reported a position in CRSP in Q1 2018 and has held it in 15 quarters since. 523 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Quantbot Technologies held 17,880 shares of CRISPR Therapeutics worth $975K as of Q2 2026.
  • Quantbot Technologies bought 16,481 CRISPR Therapeutics shares in Q2 2026, an estimated $869K.
  • CRISPR Therapeutics made up 0.04% of Quantbot Technologies's portfolio in Q2 2026, its #649 holding.
  • Quantbot Technologies first reported a position in CRISPR Therapeutics in Q1 2018 and has held it in 15 quarters since.
  • 523 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.